Global AI-enabled drug discovery and clinical trials market by region 2030
The AI-enabled drug discovery and clinical trials market worldwide is on the rise. The compound annual growth rate for the period 2019-2030 is expected to be at around 25 percent. By 2030, the market is projected to be dominated by North America, generating around 58 percent of global market revenues.